Ise, Mikiko <br/><br/>
Hepatic extramedullary disease in multiple myeloma with 17p deletion.  [electronic resource] 

 -  Clinical lymphoma, myeloma & leukemia  Oct 2014 
 - e165-8 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>2152-2669 
<br/><br/><label>Standard No.: </label>10.1016/j.clml.2014.04.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aneuploidy<br/>Angiogenesis Inhibitors--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Boronic Acids--administration & dosage<br/>Bortezomib<br/>Chromosome Aberrations<br/>Chromosome Deletion<br/>Chromosomes, Human, Pair 17--ultrastructure<br/>Clone Cells--chemistry<br/>Dexamethasone--administration & dosage<br/>Fatal Outcome<br/>Female<br/>Gene Deletion<br/>Genes, p53<br/>Humans<br/>Incidental Findings<br/>Lenalidomide<br/>Liver--pathology<br/>Middle Aged<br/>Multiple Myeloma--chemistry<br/>Neoplasm Proteins--analysis<br/>Neoplasms, Multiple Primary<br/>Osteolysis--diagnosis<br/>Proteasome Inhibitors--administration & dosage<br/>Pyrazines--administration & dosage<br/>Recurrence<br/>Thalidomide--administration & dosage<br/>Tumor Suppressor Protein p53--analysis<br/>Uterine Neoplasms--surgery